ATE163676T1 - Molekulare klone von hiv-1 und deren verwendung - Google Patents

Molekulare klone von hiv-1 und deren verwendung

Info

Publication number
ATE163676T1
ATE163676T1 AT91920794T AT91920794T ATE163676T1 AT E163676 T1 ATE163676 T1 AT E163676T1 AT 91920794 T AT91920794 T AT 91920794T AT 91920794 T AT91920794 T AT 91920794T AT E163676 T1 ATE163676 T1 AT E163676T1
Authority
AT
Austria
Prior art keywords
hiv
present
relates
dna segments
molecular clones
Prior art date
Application number
AT91920794T
Other languages
English (en)
Inventor
Marvin S Reitz Jr
Genoveffa Franchini
Phillip D Markham
Robert C Gallo
Franco C Lori
Mikulas Popovic
Suzanne Garnter
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24399839&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE163676(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of ATE163676T1 publication Critical patent/ATE163676T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT91920794T 1990-10-17 1991-10-17 Molekulare klone von hiv-1 und deren verwendung ATE163676T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59949190A 1990-10-17 1990-10-17

Publications (1)

Publication Number Publication Date
ATE163676T1 true ATE163676T1 (de) 1998-03-15

Family

ID=24399839

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91920794T ATE163676T1 (de) 1990-10-17 1991-10-17 Molekulare klone von hiv-1 und deren verwendung

Country Status (10)

Country Link
US (3) US5420030A (de)
EP (1) EP0554389B2 (de)
JP (1) JP2767078B2 (de)
AT (1) ATE163676T1 (de)
AU (1) AU649502B2 (de)
CA (1) CA2093427C (de)
DE (1) DE69129034T3 (de)
DK (1) DK0554389T4 (de)
ES (1) ES2115622T5 (de)
WO (1) WO1992006990A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341423C (en) * 1984-10-31 2003-03-04 Paul A. Luciw Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
DE4228787A1 (de) * 1992-08-29 1994-03-03 Chemotherapeutisches Forschungsinstitut Georg Speyer Haus Neue HIV-1-Virusisolate eines Subtyps, Vakzine gegen HIV-1-Virusinfektionen dieses Subtyps und Verfahren zu ihrer Herstellung, Verwendung der HIV-1-Virusisolate
EP0591914B2 (de) * 1992-10-06 2010-02-10 Siemens Healthcare Diagnostics Products GmbH Retrovirus aus der HIV-Gruppe und dessen Verwendung
AU700371B2 (en) * 1993-06-07 1999-01-07 Genentech Inc. Hiv envelope polypeptides
ES2196018T3 (es) * 1993-08-11 2003-12-16 Wyeth Corp Vacunas de adenovirus recombinantes.
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
US6585979B1 (en) 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition
FR2756843B1 (fr) * 1996-12-09 1999-01-22 Inst Nat Sante Rech Med Souches de vih-1 non-m non-o, fragments et applications
US6001558A (en) * 1997-06-25 1999-12-14 Ortho Clinical Diagnostics, Inc. Amplification and detection of HIV-1 and/or HIV 2
US6322976B1 (en) * 1998-05-28 2001-11-27 Medical Research Council Compositions and methods of disease diagnosis and therapy
US6908612B2 (en) 1999-10-08 2005-06-21 University Of Maryland Biotechnology Institute Virus coat protein/receptor chimeras and methods of use
US7311920B1 (en) 1999-10-08 2007-12-25 University Of Maryland Biotechnology Institute Virus coat protein/receptor chimeras and methods of use
US6582920B2 (en) 2000-09-01 2003-06-24 Gen-Probe Incorporated Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations
EP2020450B9 (de) 2000-09-01 2011-09-14 Gen-Probe Incorporated HIV-1-Sequenzverstärkung zur Erkennung von Sequenzen in Zusammenhang mit Wirkstoffresistenz-Mutationen
JP2006504435A (ja) * 2002-05-10 2006-02-09 ザ ヘンリー エム． ジャクソン ファウンデイション ＨＩＶ−１のｇｐ１２０のｇｐ４１への相互作用部位
US7901690B2 (en) * 2002-12-03 2011-03-08 University Of Massachusetts Polyvalent, primary HIV-1 glycoprotein DNA vaccines and vaccination methods
JP4038679B2 (ja) * 2003-05-13 2008-01-30 住友電気工業株式会社 半導体レーザーバーの固定用治具
US20080181906A1 (en) * 2003-05-19 2008-07-31 Haynes Barton F Polyvalent Immunogen
JP2010521156A (ja) * 2007-03-16 2010-06-24 ４５４ ライフ サイエンシーズ コーポレイション Ｈｉｖ薬物耐性バリアントの検出のためのシステムおよび方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6226300A (ja) * 1984-10-10 1987-02-04 セントコ−・インコ−ポレ−テツド Ｈｔｌｖ−３ｄｎａのクロ−ニングおよび発現
US5820865A (en) * 1988-01-26 1998-10-13 The United States Of America As Represented By The Department Of Health And Human Services Method to induce cytotoxic T Lymphocytes specific for a broad array of HIV-1 isolates using hybrid synthetic peptides
IL89567A0 (en) * 1988-03-28 1989-09-10 Univ Leland Stanford Junior Mutated hiv envelope protein
WO1990014427A2 (en) * 1989-05-25 1990-11-29 Sandoz Ltd Multivalent repressor of gene function
JPH05507559A (ja) * 1990-06-08 1993-10-28 レプリジェン、コーポレーション 抗ｈｉｖ―１抗体に関するイムノアッセイ

Also Published As

Publication number Publication date
JP2767078B2 (ja) 1998-06-18
AU649502B2 (en) 1994-05-26
ES2115622T5 (es) 2003-03-16
ES2115622T3 (es) 1998-07-01
DE69129034D1 (de) 1998-04-09
JPH05507205A (ja) 1993-10-21
EP0554389B1 (de) 1998-03-04
EP0554389B2 (de) 2002-08-14
US5420030A (en) 1995-05-30
DE69129034T2 (de) 1998-10-08
AU8936391A (en) 1992-05-20
WO1992006990A1 (en) 1992-04-30
CA2093427A1 (en) 1992-04-18
US5576000A (en) 1996-11-19
US5869313A (en) 1999-02-09
EP0554389A4 (en) 1994-07-06
CA2093427C (en) 2008-01-15
DK0554389T4 (da) 2002-11-11
DE69129034T3 (de) 2003-05-08
EP0554389A1 (de) 1993-08-11
DK0554389T3 (da) 1998-12-07

Similar Documents

Publication Publication Date Title
ATE163676T1 (de) Molekulare klone von hiv-1 und deren verwendung
Bryan Vinblastine and microtubules: II. Characterization of two protein subunits from the isolated crystals
BR7908410A (pt) Meio para deteccao de anticorpos de vhb no soro do sangue,e processo para deteccao da presenca da infeccao por virus da hepatite b em seres humanos
BR9711457A (pt) Compostos e processo para o tratamento e diagnóstico de infecções micobacterianas.
ATE294864T1 (de) Äusseres membranprotein von haemophilus
BG100771A (bg) Хематопоетичен протеин и материали и методи за неговото получаване
ATE90384T1 (de) Rekombinante virusproteine begleitet von lymphadenopathischem syndrom und/oder ''acquired immune deficiency syndrome'' (aids).
KR950032279A (ko) 인체의 프로그램된 세포 사멸과 관련 있는 펩티드 및 이를 암호하는 디엔에이(dna)
ATE110782T1 (de) Rekombinanter menschlicher endothelzellenwachstumsfaktor.
EE200200709A (et) Liitvalku sisaldava kompositsiooni ning seda liitvalku ja liitpolüpeptiidi kodeeriva nukleiinhappe kasutamine
DE69737125D1 (de) Streptococcus pneumoniae antigene und impfstoffe
AR038568A1 (es) Anticuerpos anti-a beta y su uso
ES2099066T3 (es) Antigenos a partir de adn sintetico derivado del virus de la inmunodeficiencia humana (hiv-1).
NO861355L (no) Ekspresjon av immunologisk reaktive virusproteiner.
ES2072928T3 (es) Antigenos de celulas de islotes pancreaticos obtenidos por clonaje molecular.
FR2660757B1 (fr) Procede d'identification ou de dosage de proteines et applications.
ATE349533T1 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
DE59508137D1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
Murphy et al. Purification of an endogenous pyrogen, with an appendix on assay methods
DK0491713T3 (da) Rubella El-peptider og C-peptider
ATE122055T1 (de) Dna- und rna-moleküle des westlichen subtyps des fsme-virus, polypeptide, die von diesen molekülen codiert werden, und deren verwendung.
DE69934953D1 (de) Impstoffe gegen Coccidiosis
AU4981093A (en) Nucleotide sequences coding for cryptosporidium proteins, polypeptides coded by said sequences and kits for the use thereof
Gazitt et al. Early and late changes in the glycoproteins of Friend erythroleukemia cells induced to differentiate
Yakobson et al. Monkey interferon: activity on human cells and chromatographic properties

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0554389

Country of ref document: EP

EELA Cancelled due to lapse of time